Page last updated: 2024-08-25

sofosbuvir and uridine

sofosbuvir has been researched along with uridine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Hartmann, MD; Heim, C; Hernandez Alvarez, B; Maiwald, S1
Guinan, M; Huang, N; Miller, GJ; Smith, M1
Basalious, EB; Karim, IA; Rezk, MR1
Brainard, DM; Curtis, C; Lasseter, K; Lawitz, E; Ling, KHJ; Marbury, T; Mathias, A; Mogalian, E; Moorehead, L; Murray, B; Osinusi, A; Perry, R1
Brainard, DM; Chen, G; Chen, H; Ding, Y; Li, X; Massetto, B; Niu, J; Shen, G; Zhang, H; Zhu, X1
Algharably, E; Budde, K; Duerr, M; Glander, P; Halleck, F; Hoffmann, F; Jaeger, C; Kreutz, R; Lisec, J; Schrezenmeier, E; Schrezenmeier, J1
Chen, G; Chen, H; Ding, Y; Li, X; Niu, J; Shen, Z; Zhang, H; Zhu, X1
Burger, DM; Colbers, A; Drenth, JPH; Freriksen, JJM; Greupink, R; Meijerhof, M; Russel, FGM; van Drongelen, J1

Trials

3 trial(s) available for sofosbuvir and uridine

ArticleYear
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
    Clinical pharmacokinetics, 2018, Volume: 57, Issue:11

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Insufficiency; Hepatitis C; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Sofosbuvir; Uridine; Young Adult

2018
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjects.
    Clinical therapeutics, 2018, Volume: 40, Issue:9

    Topics: Adult; Antiviral Agents; Asian People; Female; Healthy Volunteers; Hepatitis C, Chronic; Humans; Male; Middle Aged; Sofosbuvir; Uridine; Young Adult

2018
Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects.
    Clinical pharmacology in drug development, 2019, Volume: 8, Issue:8

    Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Dose-Response Relationship, Drug; Drugs, Generic; Female; Healthy Volunteers; Hepacivirus; Humans; Male; Metabolic Clearance Rate; Sofosbuvir; Uridine

2019

Other Studies

5 other study(ies) available for sofosbuvir and uridine

ArticleYear
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay.
    ACS medicinal chemistry letters, 2021, Jan-14, Volume: 12, Issue:1

    Topics:

2021
Design, chemical synthesis and antiviral evaluation of 2'-deoxy-2'-fluoro-2'-C-methyl-4'-thionucleosides.
    Bioorganic & medicinal chemistry letters, 2022, 04-01, Volume: 61

    Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Design; Hepacivirus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thionucleosides; Virus Replication

2022
Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
    Journal of pharmaceutical and biomedical analysis, 2015, Oct-10, Volume: 114

    Topics: Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Healthy Volunteers; Humans; Limit of Detection; Plasma; Quality Control; Reproducibility of Results; Sofosbuvir; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Uridine

2015
Pharmacokinetics of Daclatasvir, Sofosbuvir, and GS-331007 in a Prospective Cohort of Hepatitis C Virus-Positive Kidney Transplant Recipients.
    Therapeutic drug monitoring, 2019, Volume: 41, Issue:1

    Topics: Antiviral Agents; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Pyrrolidines; Sofosbuvir; Transplant Recipients; Uridine; Valine

2019
Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivo.
    American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:6

    Topics: Antiviral Agents; Carbamates; Female; Hepatitis C; Humans; Imidazoles; Maternal-Fetal Exchange; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidines; Sofosbuvir; Uridine; Valine

2020